BI 730357 / Boehringer Ingelheim 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BI 730357 / Boehringer Ingelheim
ACTRN12620001092987: A study to test different doses of BI 730357 and find out the effect they have on symptoms in people with active psoriatic arthritis

Not yet recruiting
2
160
 
Boehringer Ingelheim Pty Ltd , Boehringer Ingelheim Pty Ltd
Psoriatic Arthritis
 
 
2019-001684-77: A trial to test whether BI 730357 is effective in patients with active ankylosing spondylitis A BI 730357 hatékonyságára irányuló vizsgálat aktív Bechterew-kórban szenvedő betegek körében

Ongoing
2
40
Europe
BI 730357, Film-coated tablet
Boehringer Ingelheim RCV GmbH & Co KG, Boehringer Ingelheim RCV GmbH & Co KG
axial spondyloarthritis, axial spondyloarthritis, Body processes [G] - Physical Phenomena [G01]
 
 
2018-003487-31: A study to test how well patients with plaque psoriasis tolerate BI 730357 over a longer period and how effective it is

Not yet recruiting
2
180
Europe
BI 730357, BI 730357, Film-coated tablet
Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG
Plaque Psoriasis, Psoriasis, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 

Download Options